Agronomics Limited (ANIC): Liberation Bioindustries fermentation plant build
This situation live
ANIC Agronomics Limited
19 Dec 2025 · Final stages of construction; Series A1 first close · −10% until the next step
Liberation Bioindustries is in the final stages of constructing its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 liters and a full
17 Feb 2026 · Nearing completion; first tranche closed · −14% until the next step
Liberation Bioindustries closed the first tranche of its Series A1 equity round, with its Richmond facility nearing completion and partners already preparing to utilise capacity upon commissioning.
29 Sep 2026 · Funding gap; completion slipped beyond Q4 2026 · −18% since
While timing remains uncertain, Liberation and Agronomics are working toward having a full funding package in H1 2027.
Liberation Bioindustries fermentation plant build
Funding gap; completion slipped beyond Q4 2026
Next: Full funding package for Liberation, targeted for H1 2027
Every step · 3
- 19 Dec 2025 Final stages of construction; Series A1 first close – Liberation Bioindustries is in the final stages of constructing its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility... ↗
- 17 Feb 2026 Nearing completion; first tranche closed – Liberation Bioindustries closed the first tranche of its Series A1 equity round, with its Richmond facility nearing completion and partners already... ↗
- 29 Sep 2026 Funding gap; completion slipped beyond Q4 2026 – While timing remains uncertain, Liberation and Agronomics are working toward having a full funding package in H1 2027. ↗
What is happening
Agronomics Limited: Liberation Bioindustries fermentation plant build – Funding gap; completion slipped beyond Q4 2026. ['Funding gap; completion slipped beyond Q4 2026']
- In short
- Liberation closed the first Series A1 tranche on 19 December 2025, converting Agronomics' loan notes into shares. On 29 Sep 2026 Liberation ended its four-month strategic review with no acceptable offers for a sale or JV of the Richmond facility. A c.$25m funding gap means the Q4 2026 completion target will be missed, and first production comes six months after funding. Liberation is valued at £35.28m, about 25% of NAV.
- Announced
- 19 Dec 2025 · Final stages of construction; Series A1 first close
- Latest
- 29 Sep 2026 · Funding gap; completion slipped beyond Q4 2026
- Portfolio weighting
- 25% at 31 December 2025
- Series A1
- first tranche closed 19 December 2025; loan notes converted
- Next milestone
- Full funding package targeted for H1 2027; timing uncertain
- Funding gap
- c.$25 million further funding needed; first production six months after funding is secured
- Strategic review
- Concluded 29 Sep 2026 with no acceptable offers; two lead parties in extended negotiations
- Funding sources
- Additional shareholder equity, secured debt, public authority grants and loans, customer pre-payments
- Deployed to date
- Approximately $125 million in equity, debt and other support payments
- NAV exposure
- £35.28 million, about 25% of £140 million NAV at 30 June 2026; no material NAV impact expected
What comes next
Full funding package for Liberation, targeted for H1 2027.
Briefing Pro
New to Agronomics Limited? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the ANIC briefing →From the company's own announcements. Not investment advice.
Also at Agronomics Limited 2 open
Project milestonesAll G lactoferrin US commercialisation – FDA GRAS cleared; pre-launch
OverhangBlueNalu lock-in on Agronomics shares – Shares issued; NAV uplift booked
Insider conviction1 director buying – £49k in 1 buy · closed
Insider conviction1 director buying – £146k in 2 buys · closed
Agronomics Limited – company page →